会议背景介绍:
Modern biology is moving faster than ever before and this is nowhere more obvious than in modern genetics. As the success of HGP and HapMap Project, the genodermatology research comes to the main focus in the modern dermatology. Especially recent years, the advent of Genome Wide Association Study obviously promoted the development of genodermatology. The goal of genodermatology is not only to find the etiology underlying the diseases and explain the pathway related. The more important is to make the best use of them and translate them into the clinic.
The success of the First World Congress on Genodermatology in 2007 and Second World Congress on Genodermatology in 2010 Maastricht convincingly shown that those who work in genetic skin disorders appreciate a focus for reflection. Encouraged by the enormous success and enthusiastic feedback from colleagues around the world, it has been decided to organize the Third World Congress on Genodermatology in Beijing city, the capital of China. The meeting will take place in China National Convention Central (the main news central for 2008 Beijing Olympics) from June 12 to 14, 2012. More information is available on the official website www.cmacsd.org/wcg2012.
Well-known experts from various fields of genodermatology and allied disciplines will inform us about the state of the art. The World Congress will also offer ample opportunities for young researchers to present their most recent work, giving them the chance to discuss their results with renowned experts and leaders in both basic and clinical science.
征文范围及要求：
Preparation of Your Abstract
* Abstracts must be submitted in clear English with accurate grammar and spelling of a quality suitable for publication.
* The material in the abstract must be original and not previously published.
* The title should be as brief as possible (limited to 25 words) but long enough to clearly indicate the nature of the study. Abbreviations must not be used in the title.
* The abstract is limited to maximum 250 words
* Abstracts will be reproduced exactly as submitted and will not be edited in any way. Contents may be organized as the author sees fit, though they should include the purpose of the study, the methods used, a summary of the results and the conclusion reached.
* Only standard abbreviations may be used without definition. Data must be given in units widely used in literature (International metric system is preferred).
* Use generic names. Commercial drug names may not be used. No mention of pharmaceutical company names should be included in the abstract.
* No references, tables, charts or drawings are allowed.
